TDAM USA’s Bausch Health BHC Stock Holding History

TDAM USA’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,299	Closed	-$231K	–	383
2015 Q3	$231K	Buy	1,299 +284	+28%	+$66.2K	0.01%	336
2015 Q2	$225K	Buy	+1,015	New	+$225K	0.01%	350

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

TDAM USA's BHC Position: Q4 2015 in Review

TDAM USA sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 1,299 shares — an estimated $231K sold.

TDAM USA first reported a position in BHC in Q2 2015 and held it in 2 quarters. The position peaked at $231K in Q3 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

TDAM USA reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
TDAM USA sold 1,299 Bausch Health shares in Q4 2015, an estimated $231K.
TDAM USA first reported a position in Bausch Health in Q2 2015 and held it in 2 quarters.
TDAM USA's Bausch Health position peaked at $231K in Q3 2015.
451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on TDAM USA's 13F filing for Q4 2015, filed 4 Feb 2016.